Fundacion IMIM   Report issue

Foundation Phase 1 Phase 2
Founded: Barcelona Spain (1992)

Organization Overview

First Clinical Trial
2009
NCT01788670
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fundacion IMIM | IMIM (Hospital del Mar Medical Research Institute), Barcelona | IMIM, Institut Hospital del Mar d'Investigacions Mèdiques

Active Ingredients

Drugs in Phase 2 Trials (5)

caffeine (1 trial)

dextromethorphan (delsym) (1 trial)

losartan (cozaar) (1 trial)

olive (1 trial)

omeprazole (prilosec) (1 trial)

Drugs in Phase 1 Trials (3)

ethanol (2 trials)

methylprednisolone (medrol) (1 trial)

water (1 trial)

Drugs in Other Trials (1)

l-epigallocatechin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis, Contact (Phase 1)

Obesity (Phase 2)

Obesity, Morbid (Phase 2)

Overweight (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 9